Postoperative Outcomes in Pediatric Septoplasty.


Journal

The Annals of otology, rhinology, and laryngology
ISSN: 1943-572X
Titre abrégé: Ann Otol Rhinol Laryngol
Pays: United States
ID NLM: 0407300

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 21 7 2023
pubmed: 14 10 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

Identify risk factors and perioperative morbidity for pediatric patients undergoing septoplasty. The American College of Surgeons National Surgical Quality Improvement Program Pediatric (NSQIP-P) database was retrospectively queried to identify patients who underwent septoplasty (CPT 30520) for a diagnosis of deviated nasal septum (ICD J34.2) from 2018 to 2019. Outcomes analyzed include patient demographics, medical comorbidities, surgical setting, operative characteristics, length of stay, and postoperative outcomes. A total of 729 children were identified. Median age at time of surgery was 15.8 years, with most patients (82.8%) >12 years of age; no significant association was identified between age at time of surgery and adverse surgical outcomes. Overall, postoperative complications were uncommon (0.6%), including readmission (0.4%), septic shock (0.1%), and surgical site infection (0.1%). A history of asthma was found to be a significant risk factor for postoperative complications ( The 30-day postoperative complications following pediatric septoplasty in children reported in the NSQIP-P database are infrequent. Special considerations regarding young age, complex sinonasal anatomy, and surgical technique remain important features in considering corrective surgery for the pediatric nose and certainly warrant further investigation in subsequent studies.

Identifiants

pubmed: 36226335
doi: 10.1177/00034894221129677
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1050-1058

Auteurs

Sarah Benyo (S)

Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Annie E Moroco (AE)

Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

Robert A Saadi (RA)

Department of Otolaryngology - Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Vijay A Patel (VA)

Department of Surgery, Division of Otolaryngology - Head and Neck Surgery, University of California San Diego, La Jolla, CA, USA.
Division of Pediatric Otolaryngology, Rady Children's Hospital - San Diego, San Diego, CA, USA.

Tonya S King (TS)

Department of Public Health Sciences, The Pennsylvania State University, College of Medicine, Hershey, PA, USA.

Meghan N Wilson (MN)

Department of Otolaryngology - Head and Neck Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH